Cancer medicines
Apalutamide
Apalutamide
An androgen receptor inhibitor used in selected prostate cancers.
Sources checked · Introductory guide
On this page
How it works
It blocks androgen receptor signaling to suppress cancer cell growth.[3]
Where it is used
Used in selected nonmetastatic castration-resistant or metastatic castration-sensitive prostate cancers.[1]
Key safety points
Discuss rash, falls and fracture risk. Blistering rash, mucosal sores, seizures or new breathlessness need urgent care.[2]
Questions for your care team
- What is the plan for androgen deprivation and skin, bone and thyroid monitoring?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
- NCI · Apalutamide (opens in a new tab)
- MedlinePlus · Apalutamide (opens in a new tab)
- NCI Drug Dictionary · Apalutamide (opens in a new tab)
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.